News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Nokia shares trade around $10.68, entering a technical buy zone above key moving averages.
  • Company reported multiple product wins, supporting renewed revenue momentum in networking.
  • Accelerating AI-RAN adoption and edge demand cited as key growth drivers for Nokia.
  • Macro capex tailwinds favor network vendors, potentially boosting sector investment flows.
  • Short interest remains elevated, increasing upside volatility on rallies.
  • Trade plan: buy at $10.60, stop $9.80, target $13.50 over about 45 trading days.

Latest Articles

Lifecore Biomedical Signs Three New Customer Agreements

Lifecore Biomedical Signs Three New Customer Agreements

Lifecore Biomedical announced three new customer agreements, including a late-stage regenerative medicine program and two early-stage projects supporting medical technology development. These agreements diversify Lifecore's pipeline and are expected to contribute to revenue starting in 2028, reinforcing its position as a key player in the CDMO mark…

AZZ: Secular Demand and Lower Leverage Make a Convincing Long Setup

AZZ: Secular Demand and Lower Leverage Make a Convincing Long Setup

AZZ Inc. combines structural demand for corrosion protection and power transmission with a cleaner balance sheet and improving margins. Management's FY27 guidance (sales $1.73-$1.78B, adj. EBITDA up to $400M, adj. EPS up to $7.00) plus steady free cash flow ($169M last reported) supports upside from the current price. Trade idea: enter $149.00, sto…

Cullinan Therapeutics Announces Positive End-of-Phase 1 Meeting with FDA for CLN-049 and Advances Program to a Potentially Registrational Phase 2 Study in AML

Cullinan Therapeutics Announces Positive End-of-Phase 1 Meeting with FDA for CLN-049 and Advances Program to a Potentially Registrational Phase 2 Study in AML

Cullinan Therapeutics announced a positive End-of-Phase 1 meeting with the FDA regarding their novel T cell engager CLN-049 for acute myeloid leukemia (AML). The FDA's feedback supports initiating a potentially registrational Phase 2 study in relapsed/refractory AML patients in Q3 2026. CLN-049 targets FLT3-expressing leukemia cells and has receive…

Atea Pharmaceuticals Meets Both Its Primary and Secondary Endpoints in the Phase 3 C-BEYOND North America Trial Evaluating Bemnifosbuvir/Ruzasvir for Hepatitis C Virus

Atea Pharmaceuticals Meets Both Its Primary and Secondary Endpoints in the Phase 3 C-BEYOND North America Trial Evaluating Bemnifosbuvir/Ruzasvir for Hepatitis C Virus

Atea Pharmaceuticals announced that its oral antiviral combination Bemnifosbuvir/Ruzasvir (BEM/RZR) achieved statistical non-inferiority to the standard treatment Sofosbuvir/Velpatasvir (SOF/VEL) in the Phase 3 C-BEYOND trial for treating chronic Hepatitis C Virus (HCV) infection. The 8-week BEM/RZR regimen demonstrated high cure rates across patie…

Syndax to Announce Second Quarter 2026 Financial Results and Host Conference Call and Webcast on August 4, 2026

Syndax to Announce Second Quarter 2026 Financial Results and Host Conference Call and Webcast on August 4, 2026

Syndax Pharmaceuticals, a commercial-stage biopharmaceutical company specializing in cancer therapies, announced its plan to release its second quarter 2026 financial results on August 4, 2026, followed by a conference call and webcast. The company highlighted its FDA-approved products Revuforj® and Niktimvo™ and ongoing clinical trials as part of …

Altimmune Announces Positive Topline Results from RECLAIM Phase 2 Trial of Pemvidutide in Alcohol Use Disorder

Altimmune Announces Positive Topline Results from RECLAIM Phase 2 Trial of Pemvidutide in Alcohol Use Disorder

Altimmune, Inc. announced positive topline results from its RECLAIM Phase 2 trial of pemvidutide, a dual glucagon/GLP-1 receptor agonist, in patients with moderate to severe alcohol use disorder. The trial met its primary endpoint with a statistically significant reduction in heavy drinking days and achieved key secondary endpoints recognized by th…

Factorial Sets Date for Second Quarter 2026 Results

Factorial Sets Date for Second Quarter 2026 Results

Factorial Energy Inc., a Nasdaq-listed solid-state battery technology leader, will release its second quarter 2026 financial results on August 11, 2026, followed by a webcast and conference call to discuss performance and updates. The company is known for its proprietary battery platforms and collaborations with major automotive manufacturers.

SunPower Reports Q2’26 Results

SunPower Reports Q2’26 Results

SunPower Inc. reported preliminary Q2 2026 financial results showing a revenue decline to $56 million from $72.8 million in Q1, principally due to delayed jobs and quality control issues in its SunPower Direct Division. Despite the revenue drop, operating loss improved slightly due to substantial reductions in operating expenses and fixed costs. Ma…

Grace Therapeutics Announces Receipt of Type A Meeting Minutes from U.S. Food and Drug Administration

Grace Therapeutics Announces Receipt of Type A Meeting Minutes from U.S. Food and Drug Administration

Grace Therapeutics announced receipt of FDA Type A meeting minutes affirming no clinical safety or efficacy deficiencies in their GTx-104 drug candidate for aneurysmal subarachnoid hemorrhage (aSAH). The FDA's prior Complete Response Letter (CRL) cited only manufacturing compliance and additional non-clinical data requirements. The company is imple…

Repligen Reports Second Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance

Repligen Reports Second Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance

Repligen Corporation reported 12% year-over-year revenue growth in Q2 2026 with strong organic growth of 13%. The company raised its full-year 2026 organic revenue growth guidance to 10.5%-13.5% and adjusted EPS guidance to $2.03-$2.09. Additionally, Repligen announced a definitive agreement to acquire BioLife Solutions, enhancing its cell therapy …

Blue Gold Announces Appointment of Andrew Cavaghan as Chairman

Blue Gold Announces Appointment of Andrew Cavaghan as Chairman

Blue Gold Limited announced that CEO Andrew Cavaghan has been appointed Chairman of the Board, succeeding Dan Owiredu who retired after the AGM. The company indicated this leadership change reflects a shift from establishing its public platform to executing a long-term growth strategy focusing on disciplined acquisitions and operational excellence …

UPS Shares Jump After Quarterly Beat and Upgraded Full-Year Targets

UPS Shares Jump After Quarterly Beat and Upgraded Full-Year Targets

United Parcel Service reported second-quarter 2026 results that surpassed analyst estimates on both revenue and adjusted earnings per share. The company raised its full-year adjusted EPS and revenue outlooks and said it successfully executed the planned Amazon volume glide-down and related network reconfiguration. Positive analyst moves and the ear…

SNDL Reports Second Quarter 2026 Financial and Operational Results

SNDL Reports Second Quarter 2026 Financial and Operational Results

SNDL Inc. posted Q2 2026 financial results showing a 3.7% decrease in net revenue to $235.8M CAD and a 16.6% decline in gross profit due to market softness in liquor and cannabis segments and ramp-up costs. Operating loss widened to $7.8M, impacted by production inefficiencies and margin pressures, despite improvements in cash flow and maintaining …

Gulf States Back Omani Plan Letting Iran Collect Voluntary Fees for Hormuz Transit

Gulf States Back Omani Plan Letting Iran Collect Voluntary Fees for Hormuz Transit

Gulf states have given support to an Omani proposal that would permit Iran to collect voluntary fees for ships using the Strait of Hormuz, a step intended to ease disruptions to oil and gas shipments caused by the U.S.-Israeli military campaign on Iran. The plan would avoid granting Iran sole control and would model voluntary contributions on an ex…

K+S Shares Climb After BNP Paribas Upgrade Citing Stronger Farm Fundamentals

K+S Shares Climb After BNP Paribas Upgrade Citing Stronger Farm Fundamentals

Shares of German potash producer K+S AG rose more than 4% after BNP Paribas upgraded the stock and raised price targets, citing improving agricultural indicators and higher fertilizer price forecasts. The broker also adjusted ratings and targets across several fertilizer companies, arguing that market sell-offs have created selective upside opportu…

INNIO wins 1.1 Gigawatt Gas Engine Order for Major Data Center Campus

INNIO wins 1.1 Gigawatt Gas Engine Order for Major Data Center Campus

INNIO N.V. announced a significant equipment order totaling approximately 1.1 gigawatts of gas engine capacity, intended for a major developer of large-scale data center campuses in the United States. This order, one of the largest in the company's history, highlights strong growth in the data center sector's need for efficient and reliable behind-…